The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Celgene Corporation to Present at Oppenheimer's 21st Annual Healthcare Conference

Friday, October 29, 2010

Celgene Corporation to Present at Oppenheimer's 21st Annual Healthcare Conference07:30 EDT Friday, October 29, 2010 SUMMIT, N.J. (Business Wire) -- Celgene Corporation (NASDAQ: CELG) today announced its presentation at Oppenheimer's 21st Annual Healthcare Conference on Tuesday, November 2, 2010 at 11:25 a.m. ET will be webcast live and will be available in the investor relations section of the company's Web site at www.celgene.com. Celgene management will provide an overview of the company. Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's Web site at www.celgene.com. This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company's control. The company's actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. The factors that could cause actual results, performance, or achievements to differ from the forward-looking statements are discussed in the company's filings with the Securities and Exchange Commission, such as the company's Form 10-K, 10-Q and 8-K reports. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements. Celgene CorporationJacqualyn A. Fouse, 908-673-9956Sr. Vice President and Chief Financial OfficerorCelgene CorporationTim Smith, 908-673-9951DirectorInvestor Relations